PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.

Abstract This study aimed to identify prognostic factors influencing the outcome of recurrent or persistent uterine leiomyosarcoma (ULMS).
PMID
Related Publications

Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.

Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohort.

Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients.

The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.

Uterine leiomyosarcoma: an updated series.

Authors

Mayor MeshTerms
Keywords
Journal Title international journal of gynecological cancer : official journal of the international gynecological cancer society
Publication Year Start
%A Rauh-Hain, Jose Alejandro; Hinchcliff, Emily M.; Oduyebo, Titilope; Worley, Michael J.; Andrade, Carolina A.; Schorge, John O.; George, Suzanne; Muto, Micheal G.; del Carmen, Marcela G.
%T Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.
%J International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, vol. 24, no. 8, pp. 1434-1440
%D 10/2014
%V 24
%N 8
%M eng
%B This study aimed to identify prognostic factors influencing the outcome of recurrent or persistent uterine leiomyosarcoma (ULMS).
%K Adult, Aged, Aged, 80 and over, Female, Humans, Leiomyosarcoma, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local, Prognosis, Recurrence, Survival Analysis, Treatment Failure, Uterine Neoplasms
%P 1434
%L 1440
%Y 10.1097/IGC.0000000000000221
%W PHY
%G AUTHOR
%R 2014.......24.1434R

@Article{Rauh-Hain2014,
author="Rauh-Hain, Jose Alejandro
and Hinchcliff, Emily M.
and Oduyebo, Titilope
and Worley, Michael J.
and Andrade, Carolina A.
and Schorge, John O.
and George, Suzanne
and Muto, Micheal G.
and del Carmen, Marcela G.",
title="Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.",
journal="International journal of gynecological cancer : official journal of the International Gynecological Cancer Society",
year="2014",
month="Oct",
volume="24",
number="8",
pages="1434--1440",
keywords="Adult",
keywords="Aged",
keywords="Aged, 80 and over",
keywords="Female",
keywords="Humans",
keywords="Leiomyosarcoma",
keywords="Middle Aged",
keywords="Neoplasm Metastasis",
keywords="Neoplasm Recurrence, Local",
keywords="Prognosis",
keywords="Recurrence",
keywords="Survival Analysis",
keywords="Treatment Failure",
keywords="Uterine Neoplasms",
abstract="This study aimed to identify prognostic factors influencing the outcome of recurrent or persistent uterine leiomyosarcoma (ULMS).",
issn="1525-1438",
doi="10.1097/IGC.0000000000000221",
url="http://www.ncbi.nlm.nih.gov/pubmed/25248114",
language="eng"
}

%0 Journal Article
%T Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.
%A Rauh-Hain, Jose Alejandro
%A Hinchcliff, Emily M.
%A Oduyebo, Titilope
%A Worley, Michael J.
%A Andrade, Carolina A.
%A Schorge, John O.
%A George, Suzanne
%A Muto, Micheal G.
%A del Carmen, Marcela G.
%J International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
%D 2014
%8 Oct
%V 24
%N 8
%@ 1525-1438
%G eng
%F Rauh-Hain2014
%X This study aimed to identify prognostic factors influencing the outcome of recurrent or persistent uterine leiomyosarcoma (ULMS).
%K Adult
%K Aged
%K Aged, 80 and over
%K Female
%K Humans
%K Leiomyosarcoma
%K Middle Aged
%K Neoplasm Metastasis
%K Neoplasm Recurrence, Local
%K Prognosis
%K Recurrence
%K Survival Analysis
%K Treatment Failure
%K Uterine Neoplasms
%U http://dx.doi.org/10.1097/IGC.0000000000000221
%U http://www.ncbi.nlm.nih.gov/pubmed/25248114
%P 1434-1440

PT Journal
AU Rauh-Hain, JA
   Hinchcliff, EM
   Oduyebo, T
   Worley, MJ
   Andrade, CA
   Schorge, JO
   George, S
   Muto, MG
   del Carmen, MG
TI Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.
SO International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
JI Int. J. Gynecol. Cancer
PD Oct
PY 2014
BP 1434
EP 1440
VL 24
IS 8
DI 10.1097/IGC.0000000000000221
LA eng
DE Adult; Aged; Aged, 80 and over; Female; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Recurrence; Survival Analysis; Treatment Failure; Uterine Neoplasms
AB This study aimed to identify prognostic factors influencing the outcome of recurrent or persistent uterine leiomyosarcoma (ULMS).
ER

PMID- 25248114
OWN - NLM
STAT- MEDLINE
DA  - 20140924
DCOM- 20150608
IS  - 1525-1438 (Electronic)
IS  - 1048-891X (Linking)
VI  - 24
IP  - 8
DP  - 2014 Oct
TI  - Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.
PG  - 1434-40
LID - 10.1097/IGC.0000000000000221 [doi]
AB  - OBJECTIVES: This study aimed to identify prognostic factors influencing the
      outcome of recurrent or persistent uterine leiomyosarcoma (ULMS). METHODS: All
      patients with recurrent or persistent ULMS who underwent treatment at the
      participating institutions between January 2000 and December 2010 were identified
      from the tumor registry. The Kaplan-Meier method was used to generate overall
      survival data. Factors predictive of outcome were compared using the log-rank
      test and Cox proportional hazards model. RESULTS: One hundred fifteen (68.8%)
      patients who had recurrent/persistent disease were identified, 40 (34.8%) had
      persistent disease, and 75 (65.2%) had a recurrence. Median follow-up time was
      24.9 months. The 5-year postrelapse survival rate was 15% and was not
      significantly different between women with recurrent or persistent disease (16%
      vs 13%; P = 0.1). Variables identified affecting the 5-year postrelapse survival 
      rate included low number of mitosis at the time of diagnosis (<25, 25% vs 5%; P =
      0.002), time to relapse from original diagnosis (</=6 vs >6 months, 8% vs 22%; P 
      = 0.003)), and surgical treatment (17% vs 12%; P = 0.01). Age, stage,
      chemotherapy at time of original diagnosis or at the time of relapse, site of
      recurrence, and single versus multiple sites of recurrence were not associated
      with survival. In a multivariate Cox regression model, only low number of mitosis
      (hazard ratio, 0.5; 95% confidence interval, 0.3-0.8, P = 0.02) was identified as
      a predictor of overall survival. CONCLUSIONS: The prognosis of patients with
      recurrent/persistent ULMS is, in general, poor. Women who have low number of
      mitosis at the time of diagnosis seemed to have better postrelapse survival.
FAU - Rauh-Hain, Jose Alejandro
AU  - Rauh-Hain JA
AD  - *Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology,
      Massachusetts General Hospital, daggerDivision of Gynecologic Oncology, Brigham
      and Women's Hospital, and double daggerDana Farber Cancer Institute, Harvard
      Medical School, Boston, MA.
FAU - Hinchcliff, Emily M
AU  - Hinchcliff EM
FAU - Oduyebo, Titilope
AU  - Oduyebo T
FAU - Worley, Michael J Jr
AU  - Worley MJ Jr
FAU - Andrade, Carolina A
AU  - Andrade CA
FAU - Schorge, John O
AU  - Schorge JO
FAU - George, Suzanne
AU  - George S
FAU - Muto, Micheal G
AU  - Muto MG
FAU - del Carmen, Marcela G
AU  - del Carmen MG
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Int J Gynecol Cancer
JT  - International journal of gynecological cancer : official journal of the
      International Gynecological Cancer Society
JID - 9111626
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Female
MH  - Humans
MH  - Leiomyosarcoma/*diagnosis/mortality/pathology
MH  - Middle Aged
MH  - Neoplasm Metastasis
MH  - Neoplasm Recurrence, Local/*diagnosis/mortality/pathology
MH  - Prognosis
MH  - Recurrence
MH  - Survival Analysis
MH  - Treatment Failure
MH  - Uterine Neoplasms/*diagnosis/mortality/pathology
EDAT- 2014/09/24 06:00
MHDA- 2015/06/09 06:00
CRDT- 2014/09/24 06:00
AID - 10.1097/IGC.0000000000000221 [doi]
AID - 00009577-201410000-00014 [pii]
PST - ppublish
SO  - Int J Gynecol Cancer. 2014 Oct;24(8):1434-40. doi: 10.1097/IGC.0000000000000221.
TY  - JOUR
AU  - Rauh-Hain, Jose Alejandro
AU  - Hinchcliff, Emily M.
AU  - Oduyebo, Titilope
AU  - Worley, Michael J.
AU  - Andrade, Carolina A.
AU  - Schorge, John O.
AU  - George, Suzanne
AU  - Muto, Micheal G.
AU  - del Carmen, Marcela G.
PY  - 2014/Oct/
TI  - Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.
T2  - Int. J. Gynecol. Cancer
JO  - International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
SP  - 1434
EP  - 1440
VL  - 24
IS  - 8
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Female
KW  - Humans
KW  - Leiomyosarcoma
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Prognosis
KW  - Recurrence
KW  - Survival Analysis
KW  - Treatment Failure
KW  - Uterine Neoplasms
N2  - This study aimed to identify prognostic factors influencing the outcome of recurrent or persistent uterine leiomyosarcoma (ULMS).
SN  - 1525-1438
UR  - http://dx.doi.org/10.1097/IGC.0000000000000221
UR  - http://www.ncbi.nlm.nih.gov/pubmed/25248114
ID  - Rauh-Hain2014
ER  - 
<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
<b:Source>
<b:Tag>Rauh-Hain2014</b:Tag>
<b:SourceType>ArticleInAPeriodical</b:SourceType>
<b:Year>2014</b:Year>
<b:Month>Oct</b:Month>
<b:PeriodicalName>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</b:PeriodicalName>
<b:Volume>24</b:Volume>
<b:Issue>8</b:Issue>
<b:Pages>1434-1440</b:Pages>
<b:Author>
<b:Author><b:NameList>
<b:Person><b:Last>Rauh-Hain</b:Last><b:First>Jose</b:First><b:Middle>Alejandro</b:Middle></b:Person>
<b:Person><b:Last>Hinchcliff</b:Last><b:First>Emily</b:First><b:Middle>M</b:Middle></b:Person>
<b:Person><b:Last>Oduyebo</b:Last><b:First>Titilope</b:First></b:Person>
<b:Person><b:Last>Worley</b:Last><b:First>Michael</b:First><b:Middle>J</b:Middle></b:Person>
<b:Person><b:Last>Andrade</b:Last><b:First>Carolina</b:First><b:Middle>A</b:Middle></b:Person>
<b:Person><b:Last>Schorge</b:Last><b:First>John</b:First><b:Middle>O</b:Middle></b:Person>
<b:Person><b:Last>George</b:Last><b:First>Suzanne</b:First></b:Person>
<b:Person><b:Last>Muto</b:Last><b:First>Micheal</b:First><b:Middle>G</b:Middle></b:Person>
<b:Person><b:Last>del Carmen</b:Last><b:First>Marcela</b:First><b:Middle>G</b:Middle></b:Person>
</b:NameList></b:Author>
</b:Author>
<b:Title>Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.</b:Title>
 <b:ShortTitle>Int. J. Gynecol. Cancer</b:ShortTitle>
<b:Comments>This study aimed to identify prognostic factors influencing the outcome of recurrent or persistent uterine leiomyosarcoma (ULMS).</b:Comments>
</b:Source>
</b:Sources>